BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23600521)

  • 1. Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation.
    Funderburg NT; Stubblefield Park SR; Sung HC; Hardy G; Clagett B; Ignatz-Hoover J; Harding CV; Fu P; Katz JA; Lederman MM; Levine AD
    Immunology; 2013 Sep; 140(1):87-97. PubMed ID: 23600521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
    Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
    Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
    Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
    Probert CS; Chott A; Turner JR; Saubermann LJ; Stevens AC; Bodinaku K; Elson CO; Balk SP; Blumberg RS
    J Immunol; 1996 Oct; 157(7):3183-91. PubMed ID: 8816432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up.
    Roosenboom B; Wahab PJ; Smids C; Groenen MJM; van Koolwijk E; van Lochem EG; Horjus Talabur Horje CS
    Inflamm Bowel Dis; 2019 Aug; 25(9):1497-1509. PubMed ID: 30918941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytes.
    Peter J; Frey O; Stallmach A; Bruns T
    BMC Gastroenterol; 2013 Feb; 13():37. PubMed ID: 23446058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.
    Tom MR; Li J; Ueno A; Fort Gasia M; Chan R; Hung DY; Chenoo S; Iacucci M; Jijon HB; Kaplan GG; Beck PL; Panaccione R; Barkema HW; Buret AG; Yajnik V; Ghosh S
    Inflamm Bowel Dis; 2016 Jul; 22(7):1596-608. PubMed ID: 27306067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
    Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
    Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
    Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
    J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a regulatory "defect" for CD4 positive intestinal T cells in vitro in patients with IBD compared to normals.
    Niessner M; Gerok W; Volk BA
    Adv Exp Med Biol; 1995; 371B():1267-71. PubMed ID: 7502797
    [No Abstract]   [Full Text] [Related]  

  • 16. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.
    Danese S; Katz JA; Saibeni S; Papa A; Gasbarrini A; Vecchi M; Fiocchi C
    Gut; 2003 Oct; 52(10):1435-41. PubMed ID: 12970136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CCR6 and CXCR6 by Gut-Derived CD4
    Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
    Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease.
    Baumgart DC; Thomas S; Przesdzing I; Metzke D; Bielecki C; Lehmann SM; Lehnardt S; Dörffel Y; Sturm A; Scheffold A; Schmitz J; Radbruch A
    Clin Exp Immunol; 2009 Sep; 157(3):423-36. PubMed ID: 19664152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
    Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
    Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.